Tirzepatide Weight-Loss Care in NYC & Philadelphia
W8MD evaluates patients interested in tirzepatide as part of individualized medical weight management. At an initial in-person visit in Brooklyn or Philadelphia, your provider reviews your health history and discusses appropriate treatment options, insurance questions and follow-up.
W8MD pricing and program highlights
Semaglutide programs
$29.99/week+
With insurance accepted for qualifying visits; self-pay from $59.99/week and up.
Tirzepatide programs
$45/week+
With insurance accepted for qualifying visits; self-pay from $69.99/week and up.
Medical program
Personalized
Nutrition, medications, behavior support, sleep evaluation and maintenance.
Tirzepatide Weight Loss: what patients should know
W8MD evaluates eligible patients for tirzepatide options including Zepbound and Mounjaro-related care.
An individualized decision
Explain what you hope to achieve and your previous treatment experience. Your clinician considers your health, current medicines and preferences.
Product and coverage questions
Ask which product is being considered, what it is prescribed for and how your plan treats it. Product indications and pharmacy charges should be explained separately from program fees.
Follow-up and maintenance
Ask how response will be assessed and what happens if cost, availability or tolerability changes. Nutrition guidance and maintenance planning remain part of care.
Explore related care: Physician-Supervised Medical Weight Loss · Medical Weight Loss in Brooklyn, NYC · Medical Weight Loss in Northeast Philadelphia · GLP-1 Weight-Loss Care in NYC & Philadelphia · Semaglutide Weight-Loss Care in NYC & Philadelphia · Phentermine Evaluation in NYC & Philadelphia.
How W8MD can help
- Review BMI, medical history, blood pressure, medications and contraindications.
- Discuss expected benefits, side effects, cost and insurance coverage.
- Combine medication with nutrition, activity, sleep and maintenance planning.
Helpful authoritative references
W8MD keeps content aligned with current public medical information while individual treatment decisions remain personalized.
FDA Zepbound and OSA
The FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, with diet and physical activity.
FDA Wegovy HD
The FDA approved a higher-dose 7.2 mg Wegovy HD option for weight loss and long-term maintenance in certain adult patients.
Home sleep testing
The American Academy of Sleep Medicine describes home sleep apnea testing as an alternative to polysomnography for appropriate uncomplicated adults.
Learn more on WikiMD.org
W8MD active offices
W8MD serves patients in New York City, Brooklyn, New Jersey, Connecticut, Greater Philadelphia, South Jersey, Pennsylvania and Delaware through active Brooklyn and Philadelphia offices, with telemedicine options when clinically appropriate.
Brooklyn / New York City
W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235
Greater Philadelphia
W8MD Philadelphia
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115
Ready to start with W8MD?
Call Brooklyn / NYC at 718-946-5500 or Philadelphia at 215-676-2334. You can also use the form below. Please do not include sensitive medical information in this form.
